VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
DGICA
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
DGICADonegal Group Inc.
$18.83$690M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksDGICAQuarterly Financials

Donegal Group Inc. (DGICA) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Donegal Group Inc. (DGICA) quarterly income statement — complete revenue, gross profit & net income history

DGICA Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Revenue236M240.14M245.92M247.15M245.17M249.95M251.74M246.77M241.14M239.47M233.93M229.2M224.75M223.44M212.84M204.31M207.63M210.24M203.11M205.15M
Revenue Growth %-3.74%-3.93%-2.31%0.15%1.67%4.38%7.61%7.67%7.29%7.17%9.91%12.18%8.25%6.28%4.79%-0.41%4.88%6.45%3.36%3.14%
Medical Costs & Claims142M175.5M179.93M190.42M171.26M181.29M186.63M206.02M190.5M202.3M196.02M189.17M175.9M186.4M191.27M176.78M152.06M173.06M179.92M147.06M
Medical Cost Ratio %60.17%73.08%73.17%77.05%69.85%72.53%74.14%83.48%79%84.48%83.79%82.54%78.27%83.42%89.87%86.53%73.24%82.32%88.58%71.69%
Gross Profit94M64.64M65.99M56.73M73.91M68.67M65.11M40.76M50.64M37.16M37.91M40.03M48.84M37.05M21.57M27.53M55.56M37.18M23.19M58.09M
Gross Margin %39.83%26.92%26.83%22.95%30.15%27.47%25.86%16.52%21%15.52%16.21%17.46%21.73%16.58%10.13%13.47%26.76%17.68%11.42%28.31%
Gross Profit Growth %27.18%-5.86%1.34%39.19%45.94%84.76%71.74%1.82%3.69%0.32%75.76%45.39%-12.09%-0.35%-6.97%-52.6%14.39%-27.54%-49.62%-9.12%
Operating Expenses79.87M43.68M40.94M36.31M42.75M39M44.7M35.74M43.39M39.65M38.92M37.77M42.55M32.96M34.94M38.11M39.34M30.66M31.82M38.39M
OpEx / Revenue %33.85%18.19%16.65%14.69%17.44%15.6%17.76%14.48%18%16.56%16.64%16.48%18.93%14.75%16.42%18.65%18.95%14.58%15.66%18.71%
Depreciation & Amortization0425.3K717.3K912.48K1.02M995.32K980.11K930.83K966.91K1.11M1.02M1.07M1.12M1.09M1.14M1.26M1.34M1.35M1.41M1.43M
Combined Ratio %94.02%91.27%89.81%91.74%87.29%88.13%91.89%97.97%96.99%101.04%100.43%99.02%97.2%98.17%106.28%105.18%92.18%96.9%104.25%90.4%
Operating Income14.12M20.96M25.05M20.42M31.16M29.67M20.41M5.01M7.25M-2.48M-1.01M2.25M6.3M4.08M-13.37M-10.58M16.23M6.52M-8.63M19.7M
Operating Margin %5.98%8.73%10.19%8.26%12.71%11.87%8.11%2.03%3.01%-1.04%-0.43%0.98%2.8%1.83%-6.28%-5.18%7.82%3.1%-4.25%9.6%
Operating Income Growth %-54.68%-29.35%22.73%307.47%329.9%1295.49%2130.14%122.43%15.12%-160.76%92.48%121.3%-61.2%-37.37%-54.92%-153.71%27.26%-64.66%-160.21%-29.62%
EBITDA14.46M21.38M25.77M21.34M32.18M30.66M21.39M5.94M8.22M-1.37M18.21K3.32M7.42M5.18M-12.23M-9.32M17.57M7.87M-7.22M21.13M
EBITDA Margin %6.13%8.9%10.48%8.63%13.13%12.27%8.5%2.41%3.41%-0.57%0.01%1.45%3.3%2.32%-5.75%-4.56%8.46%3.74%-3.55%10.3%
Interest Expense333K340.43K340.43K336.7K333.05K269.25K367.58K154.59K154.6K155.9K156.32K154.64K152.96K156.37K71.43K239.72K153.03K156.44K209.55K217.29K
Non-Operating Income-333K-340.29K-340.7K-336.7K-333.05K-269.74K-368.05K-154.59K-154.6K-155.9K-156.8K-154.64K-152.96K-156.37K-71.43K-239.72K-153.03K-156.44K-209.55K-217.29K
Pretax Income14.12M20.96M25.05M20.42M31.16M29.67M20.41M5.01M7.25M-2.48M-1M2.25M6.3M4.08M-13.37M-10.58M16.23M6.52M-8.63M19.7M
Pretax Margin %5.98%8.73%10.19%8.26%12.71%11.87%8.11%2.03%3.01%-1.04%-0.43%0.98%2.8%1.83%-6.28%-5.18%7.82%3.1%-4.25%9.6%
Income Tax2.61M3.77M4.97M3.56M5.96M5.66M3.66M859.66K1.29M-511.31K-199.61K256.06K1.09M604.75K-2.99M-2.37M3.08M1.25M-1.92M3.53M
Effective Tax Rate %18.49%17.98%19.84%17.42%19.11%19.09%17.93%17.15%17.84%20.6%19.86%11.36%17.36%14.81%22.39%22.42%18.99%19.15%22.22%17.94%
Net Income11.51M17.19M20.08M16.87M25.21M24M16.75M4.15M5.96M-1.97M-805.3K2M5.2M3.48M-10.38M-8.21M13.15M5.27M-6.71M16.16M
Net Margin %4.88%7.16%8.17%6.82%10.28%9.6%6.65%1.68%2.47%-0.82%-0.34%0.87%2.32%1.56%-4.88%-4.02%6.33%2.51%-3.3%7.88%
Net Income Growth %-54.33%-28.39%19.87%306.14%323.22%1318.26%2180.16%107.91%14.45%-156.63%92.24%124.34%-60.41%-34.01%-54.59%-150.78%24.84%-63.81%-156.7%-28.73%
EPS (Diluted)0.310.470.600.460.700.730.500.130.18-0.06-0.020.060.160.11-0.33-0.260.430.17-0.210.53
EPS Growth %-55.71%-35.62%20%253.85%288.89%1333.11%2600%116.67%12.5%-153.82%93.94%123.08%-62.79%-35.29%-57.14%-149.06%22.86%-65.31%-151.22%-32.05%
EPS (Basic)0.320.480.560.470.710.730.500.130.18-0.06-0.020.060.160.11-0.33-0.260.430.17-0.210.53
Diluted Shares Outstanding36.95M31.76M31.07M36.36M36.01M33.08M33.63M33.42M33.42M33.3M33.24M33.07M32.94M32.63M32.36M31.65M31.39M31.38M31.41M31.17M